[ad_1] By Geoff Percival Amryt Pharma, an Irish orphan drug company, plans to expand its portfolio of treatments for rare diseases. In an update of its turnover, growth reached 14 million euros. …
Read More »Amryt Pharma seeks to expand its drug portfolio
